Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety.

Costa L, Caso F, Maione F, Giacomelli R, Ruscitti P

DOI: 10.2147/dddt.s611564
Published: 2026
Container: Drug design, development and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s611564,
  title = {Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety.},
  author = {Costa L and Caso F and Maione F and Giacomelli R and Ruscitti P},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s611564},
  url = {https://doi.org/10.2147/dddt.s611564}
}

RIS

TY  - JOUR
TI  - Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety.
AU  - Costa L
AU  - Caso F
AU  - Maione F
AU  - Giacomelli R
AU  - Ruscitti P
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s611564
UR  - https://doi.org/10.2147/dddt.s611564
ER  -

APA

L, C., F, C., F, M., R, G., & P, R. (2026). Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety.. Drug design, development and therapy. https://doi.org/10.2147/dddt.s611564

Source records

pubmed · retrieved 2026-09-25T21:31:42.667Z